916 related articles for article (PubMed ID: 4248913)
21. Dissociation of clot retraction from platelet granule fusion and degranulation: an ultrastructural study of Reptilase-human platelet-rich plasma clots.
De Clerck F; Borgers M; de Gaetano G; Vermylen J
Br J Haematol; 1975 Feb; 29(2):341-8. PubMed ID: 1191554
[TBL] [Abstract][Full Text] [Related]
22. Quantification and optimization of clot retraction in washed human platelets by Sonoclot coagulation analysis.
Yadav P; Beura SK; Panigrahi AR; Singh SK
Int J Lab Hematol; 2022 Feb; 44(1):177-185. PubMed ID: 34609044
[TBL] [Abstract][Full Text] [Related]
23. Characterization of a potent platelet aggregation inhibitor from Agkistrodon rhodostoma snake venom.
Huang TF; Wu YJ; Ouyang C
Biochim Biophys Acta; 1987 Sep; 925(3):248-57. PubMed ID: 3620499
[TBL] [Abstract][Full Text] [Related]
24. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.
Kumar R; Béguin S; Hemker HC
Thromb Haemost; 1995 Sep; 74(3):962-8. PubMed ID: 8571330
[TBL] [Abstract][Full Text] [Related]
25. ClfA(221-550), a fibrinogen-binding segment of Staphylococcus aureus clumping factor A, disrupts fibrinogen function.
Liu CZ; Shih MH; Tsai PJ
Thromb Haemost; 2005 Aug; 94(2):286-94. PubMed ID: 16113817
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of clot lysis and decreased binding of tissue-type plasminogen activator as a consequence of clot retraction.
Kunitada S; FitzGerald GA; Fitzgerald DJ
Blood; 1992 Mar; 79(6):1420-7. PubMed ID: 1547340
[TBL] [Abstract][Full Text] [Related]
27. A role for platelets and thrombin in the juvenile stroke of two siblings with defective thrombin-adsorbing capacity of fibrin(ogen).
Di Minno G; Martinez J; Cirillo F; Cerbone AM; Silver MJ; Colucci M; Margaglione M; Tauro R; Semeraro N; Quattrone A
Arterioscler Thromb; 1991; 11(4):785-96. PubMed ID: 1829631
[TBL] [Abstract][Full Text] [Related]
28. Effects of alpha-tocopherol on platelets and the coagulation system.
Bakaltcheva I; Gyimah D; Reid T
Platelets; 2001 Nov; 12(7):389-94. PubMed ID: 11674855
[TBL] [Abstract][Full Text] [Related]
29. Effects of prostaglandins, derivatives of cyclic 3':5'-AMP, theophylline, cholinergic agents and colchicine on clot retraction in dilute platelet-rich plasma and gel-separated platelet test systems.
Moake JL; Cimo PL; Widmer K; Peterson DM; Gum JR
Thromb Haemost; 1977 Aug; 38(2):420-8. PubMed ID: 202038
[TBL] [Abstract][Full Text] [Related]
30. Whole blood clot lysis: in vitro modulation by activated protein C.
Taylor FB; Lockhart MS
Thromb Res; 1985 Mar; 37(6):639-49. PubMed ID: 3838829
[TBL] [Abstract][Full Text] [Related]
31. Clot retraction is mediated by factor XIII-dependent fibrin-αIIbβ3-myosin axis in platelet sphingomyelin-rich membrane rafts.
Kasahara K; Kaneda M; Miki T; Iida K; Sekino-Suzuki N; Kawashima I; Suzuki H; Shimonaka M; Arai M; Ohno-Iwashita Y; Kojima S; Abe M; Kobayashi T; Okazaki T; Souri M; Ichinose A; Yamamoto N
Blood; 2013 Nov; 122(19):3340-8. PubMed ID: 24002447
[TBL] [Abstract][Full Text] [Related]
32. Influence of thrombolytic agents on human platelet function.
Rao GH; Wilson RF; White CW; White JG
Thromb Res; 1991 May; 62(4):319-34. PubMed ID: 1866714
[TBL] [Abstract][Full Text] [Related]
33. Effects of ionic and nonionic contrast media on clot structure, platelet function and thrombolysis mediated by tissue plasminogen activator in plasma clots.
Carr ME; Carr SL; Merten SR
Haemostasis; 1995; 25(4):172-81. PubMed ID: 7557656
[TBL] [Abstract][Full Text] [Related]
34. Effect of purified Vipera palestinae hemorrhagin on blood coagulation and platelet function.
Grotto L; Jerushalmy Z; De Vries A
Thromb Diath Haemorrh; 1969 Dec; 22(3):482-95. PubMed ID: 5382286
[No Abstract] [Full Text] [Related]
35. Stabilization of platelet-fibrinogen interactions: modulation by divalent cations.
Peerschke EI
J Lab Clin Med; 1993 Jan; 121(1):135-41. PubMed ID: 8426076
[TBL] [Abstract][Full Text] [Related]
36. Additive roles of platelets and fibrinogen in whole-blood fibrin clot formation upon dilution as assessed by thromboelastometry.
Ninivaggi M; Feijge MA; Baaten CC; Kuiper GJ; Marcus MA; Ten Cate H; Lancé MD; Heemskerk JW; van der Meijden PE
Thromb Haemost; 2014 Mar; 111(3):447-57. PubMed ID: 24258426
[TBL] [Abstract][Full Text] [Related]
37. Inhibition by Argatroban, a specific thrombin inhibitor, of platelet activation by fibrin clot-associated thrombin.
Lunven C; Gauffeny C; Lecoffre C; O'Brien DP; Roome NO; Berry CN
Thromb Haemost; 1996 Jan; 75(1):154-60. PubMed ID: 8713795
[TBL] [Abstract][Full Text] [Related]
38. A method for the quantitative assessment of platelet-induced clot retraction and clot strength in fresh and stored platelets.
Reid TJ; Snider R; Hartman K; Greilich PE; Carr ME; Alving BM
Vox Sang; 1998; 75(4):270-7. PubMed ID: 9873262
[TBL] [Abstract][Full Text] [Related]
39. Role of thrombin compared with factor Xa in the procoagulant activity of whole blood clots.
Prager NA; Abendschein DR; McKenzie CR; Eisenberg PR
Circulation; 1995 Aug; 92(4):962-7. PubMed ID: 7641380
[TBL] [Abstract][Full Text] [Related]
40. Thrombin interaction with human platelets. Potentiation of thrombin-induced aggregation and release by inactivated thrombin.
Phillips DR
Thromb Diath Haemorrh; 1974 Sep; 32(1):207-15. PubMed ID: 4454040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
